Is the Cost of Cancer Medication Worthwhile?

  Is the Cost of Cancer Medication Worthwhile? Rabin Medical Center’s Dr. Daniel Goldstein explores the rising price of cancer medications and creates an equation to see if the cost is in fact justified. Dr. Goldstein is at the forefront of the fight between oncologists and pharmaceutical companies with research that will help determine if…

A Nutritional Intervention Decreases Breast Density in BRCA Carriers

Women who are carriers of the BRCA gene mutation are at high risk of developing breast cancer, and there is a large body of evidence suggesting that 3,3-diindolylmethane (DIM), a dimer of indole-3-carbinol found in cruciferous vegetables, can potentially prevent carcinogenics and tumor development. DIM is a popular food supplement and the National Cancer insitiute…